AstraZeneca, Sanofi RSV Drug for Infants Wins CDC Backing
A drug from AstraZeneca Plc and Sanofi to protect infants against a potentially fatal respiratory illness won backing Thursday from US public health advisers, moving it closer to being administered alongside other childhood immunizations.








